|
|
Inspire Medical Systems inc (NYSE: INSP) |
|
Price: $63.0800
$0.94 
1.513%
|
| Day's High:
| $63.43000030517578
| Week Perf:
| 0.14 %
|
| Day's Low: |
$ 60.03 |
30 Day Perf: |
7.11 % |
| Volume (M): |
425,705 |
52 Wk High: |
$ 147.03 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$68.92 |
| Open: |
$61.00 |
52 Wk Low: |
$38.91 |
|
|
| Market Capitalization (Millions $) |
1,810 |
| Shares
Outstanding (Millions) |
29 |
| Employees |
1,333 |
| Revenues (TTM) (Millions $) |
915 |
| Net Income (TTM) (Millions $) |
131 |
| Cash Flow (TTM) (Millions $) |
45 |
| Capital Exp. (TTM) (Millions $) |
40 |
Business Description
Inspire Medical Systems Inc. is a medical technology company that specializes in the development of innovative solutions to treating obstructive sleep apnea (OSA). The company was founded in 2007, and its headquarters are located in Minneapolis, Minnesota, USA.
Inspire Medical Systemse primary product is an implantable device that stimulates the hypoglossal nerve, which controls the tongue and other muscles involved in breathing, to prevent airway blockage and allow for normal breathing during sleep. The device is implanted under the skin in the upper chest area, and a small remote control is used to turn it on and off.
The company has conducted extensive clinical trials to prove the safety and effectiveness of the device, and it has received approval from the US Food and Drug Administration (FDA) in 2014. The device is also approved for use in Europe, Canada, and Australia.
Inspire Medical Systems is dedicated to improving the lives of people with OSA who cannot tolerate continuous positive airway pressure (CPAP), which is the standard of care for OSA. The company believes that its device provides an effective and long-term solution for patients with OSA who struggle with CPAP therapy.
In addition to developing its implantable device, Inspire Medical Systems also provides training and support for healthcare providers who diagnose and treat OSA. The company works with sleep centers and hospitals around the world to educate clinicians about the benefits of its device and the importance of early intervention for OSA.
Inspire Medical Systems has a team of experienced executives and engineers who are focused on innovation and improving patient outcomes. The company has received numerous awards and honors for its breakthrough technology, including the 2020 Fast Company Most Innovative Companies award in the medical devices category.
In summary, Inspire Medical Systems is a medical technology company that has developed an implantable device to treat obstructive sleep apnea. The company is dedicated to improving patient outcomes and provides training and support to healthcare providers. With its innovative technology and experienced team, Inspire Medical Systems is poised to continue making significant advances in the field of sleep medicine.
Company Address: 5500 Wayzata Blvd. Golden Valley 55416 MN
Company Phone Number: 672-4357 Stock Exchange / Ticker: NYSE INSP
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Announcement
Published Wed, Nov 12 2025 5:39 PM UTC
Stride, Inc. Under Legal Scrutiny Amidst Competitive Market Pressures: A Comprehensive Analysis of Its Financial Standing In a landscape increasingly marked by shareholder activism and scrutiny, Stride, Inc. (NYSE: INSP) has found itself facing a significant class action lawsuit, raising pivotal questions about its governance and operational performance. Announced on Novembe...
|
| Financing Agreement
Published Mon, Nov 11 2024 11:45 AM UTC
Inspire Medical Systems, Inc. Strengthens Shareholder Value with $75 Million Accelerated Share Repurchase ProgramIn a strategic move to bolster shareholder value, Inspire Medical Systems, Inc. (NYSE: INSP), a pioneering medical technology company renowned for its innovative, minimally invasive solutions for patients suffering from obstructive sleep apnea, announced the initi...
|
| Shares
Published Tue, Aug 6 2024 8:02 PM UTC
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
MINNEAPOLIS, Aug. 06, 2024 - Inspire Medical Systems, Inc. (NYSE: INSP), a leading medical technology company specializing in innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), has recently announced that its Board of Directors has authorized a share repurcha...
|
| Management Announcement
Published Fri, Aug 2 2024 12:01 PM UTC
In a recent press release, Inspire Medical Systems, Inc. (NYSE: INSP) announced the FDA s approval of its Inspire V therapy system. This marks a significant milestone for the medical technology company, which specializes in developing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). However, this positive news comes amidst fin...
|
| Management Announcement
Published Tue, Jul 23 2024 12:00 PM UTC
Inspire Medical Systems, Inc. has recently made a significant stride in France with the publication of reimbursement for its innovative therapy aimed at treating obstructive sleep apnea (OSA). This favorable development comes at a crucial time for the company, as it grapples with a recorded net loss of $16 million in the first quarter of 2024, resulting in a negati...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
4.4 $ |
| Revenues (TTM) |
31.88 $
|
| Cash Flow (TTM) |
1.57 $ |
| Cash |
9.89 $
|
| Book Value |
27.61 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
686,467 |
| Net
Income per Employee (TTM) |
98,377 |
| Receivable Turnover Ratio (TTM) |
7.78 |
| Inventory Turnover Ratio (TTM) |
0.9 |
| Asset Turnover Ratio (TTM) |
1.08 |
|
|
| Per Share |
|
| Earnings (TTM) |
4.4 $
|
| Revenues (TTM) |
31.88 $ |
| Cash Flow (TTM) |
1.57 $ |
| Cash |
9.89 $
|
| Book Value |
27.61 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Segment |
|
 100.33 % |
of total Revenue |
| United States |
|
95.93 % |
of total Revenue |
| International |
|
4.4 % |
of total Revenue |
| |
On February 10 2025 the Inspire Medical Systems Inc provided following guidance
Inspire Medical Systems, Inc. recently disclosed its financial performance for the fourth quarter and the entire year of 2024, alongside an update regarding its financial outlook for 2025. The company has shared its expectations for the upcoming year but, unfortunately, has not detailed specific financial estimates or projections.
In the fourth quarter of 2024, Inspire Medical Systems showcased a remarkable year-over-year revenue increase of 25%. Furthermore, the company reported an impressive growth in earnings per share, which surged by 135% compared to the same quarter the previous year. These strong performance indicators highlight the company's continued momentum and operational efficiency as i...
|
|
|
2.05%